Search research articles
Contact Us
Filters
Showing results (471-480 of 526) with videos related to
Page
of 53
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2019
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Per Ljungman, Michael Schmitt, Francisco M Marty, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2018
Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma
Biao Lu, Xiaodong Shen, Lei Zhang, et al.
Zhen Ci Yan Jiu = Acupuncture Research
|
June 25, 2026
[Effect of acupuncture combined with medicine on indomethacin-induced colonic injury in mice based on the Nrf2/HO-1 signaling pathway]
Wen Wang, Yu-Jun Hou, Kai Wang, et al.
The Journal of Infectious Diseases
|
November 30, 2019
Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
Cameron M Douglas, Richard Barnard, Daniel Holder, et al.
The Journal of Investigative Dermatology
|
February 14, 2002
Compound heterozygosity for non-sense and mis-sense mutations in desmoplakin underlies skin fragility/woolly hair syndrome
Neil V Whittock, Hong Wan, Susan M Morley, et al.
Chinese Medical Journal
|
March 11, 2022
Intensive phototherapy vs. exchange transfusion for the treatment of neonatal hyperbilirubinemia: a multicenter retrospective cohort study
Meng Zhang, Yang He, Jun Tang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 11, 2022
Discovery of novel spiro compound as RAF kinase inhibitor with in vitro potency against KRAS mutant cancer
Peng Zhao, Xiangzhu Wang, Linghang Zhuang, et al.
Frontiers in Pharmacology
|
September 27, 2021
Metabolomics Analysis Reveals Interaction of Base-Line Chemotherapy and Shiyiwei Shenqi Tablets in Breast Cancer Treatment
Hong Wan, Xiaojun Xu, Xiaowei Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2016
Discovery of EBI-907: A highly potent and orally active B-Raf(V600E) inhibitor for the treatment of melanoma and associated cancers
Biao Lu, Hu Cao, Jingsong Cao, et al.
Acta Pharmacologica Sinica
|
November 16, 2019
[1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation
Yi-Hong Wan, Wen-Yu Wu, Song-Xin Guo, et al.
Page
of 53
Search research articles
Search
Showing results (471-480 of 526) with videos related to
Sort By:
Page
of 53
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2019
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Per Ljungman, Michael Schmitt, Francisco M Marty, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2018
Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma
Biao Lu, Xiaodong Shen, Lei Zhang, et al.
Zhen Ci Yan Jiu = Acupuncture Research
|
June 25, 2026
[Effect of acupuncture combined with medicine on indomethacin-induced colonic injury in mice based on the Nrf2/HO-1 signaling pathway]
Wen Wang, Yu-Jun Hou, Kai Wang, et al.
The Journal of Infectious Diseases
|
November 30, 2019
Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
Cameron M Douglas, Richard Barnard, Daniel Holder, et al.
The Journal of Investigative Dermatology
|
February 14, 2002
Compound heterozygosity for non-sense and mis-sense mutations in desmoplakin underlies skin fragility/woolly hair syndrome
Neil V Whittock, Hong Wan, Susan M Morley, et al.
Chinese Medical Journal
|
March 11, 2022
Intensive phototherapy vs. exchange transfusion for the treatment of neonatal hyperbilirubinemia: a multicenter retrospective cohort study
Meng Zhang, Yang He, Jun Tang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 11, 2022
Discovery of novel spiro compound as RAF kinase inhibitor with in vitro potency against KRAS mutant cancer
Peng Zhao, Xiangzhu Wang, Linghang Zhuang, et al.
Frontiers in Pharmacology
|
September 27, 2021
Metabolomics Analysis Reveals Interaction of Base-Line Chemotherapy and Shiyiwei Shenqi Tablets in Breast Cancer Treatment
Hong Wan, Xiaojun Xu, Xiaowei Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2016
Discovery of EBI-907: A highly potent and orally active B-Raf(V600E) inhibitor for the treatment of melanoma and associated cancers
Biao Lu, Hu Cao, Jingsong Cao, et al.
Acta Pharmacologica Sinica
|
November 16, 2019
[1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation
Yi-Hong Wan, Wen-Yu Wu, Song-Xin Guo, et al.
Page
of 53